ArticleJournal of neurology2014
Severe familial paroxysmal exercise-induced dyskinesia.
Article in Journal of neurology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 11 citations in OpenAlex.
- Genetic Links to Episodic Movement Disorders: Current Insights.The application of clinical genetics · 2023Review
- Varied phenotypic spectrum presenting of paroxysmal exercise-induced dyskinesia: a Turkish family with SLC2A1 mutation.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Familial paroxysmal exercise-induced dyskinesia (PED) is a rare movement disorder that is mostly caused by mutations in the solute carrier family 2, member 1 (SLC2A1) gene and inherited in an autosomal dominant manner. Clinical, laboratory, and genetic studies were performed in three family members. The proband's symptoms were recorded in a private video. He was placed on clonazepam. The 42-year-old proband presented with a 34-year-history of "dancing fits" suggesting a psychogenic aetiology. They occurred spontaneously or were triggered by physical exercise with a frequency up to six episodes per month, duration up to 30 min and no impairment of consciousness. Cerebrospinal fluid-(CSF)-to-blood glucose ratio was slightly reduced (0.59) and electroencephalograms were unremarkable. His 63-year-old father had less severe symptoms with spontaneous recovery before age of 45. The proband and his 38-year-old only brother also reported daily absence episodes early in the morning with an onset at age three and spontaneous recovery before age 15. Genetic testing revealed a novel c.972G>A, p.S324S heterozygous variant in the SLC2A1 gene in three patients. No splicing defects at the RNA level could be demonstrated. Five milligrams per day of clonazepam allowed for excellent control of PED. PED may produce a broad range of bizarre movements mimicking psychogenic movement disorders. A positive family history suggests an organic aetiology. PED can effectively be treated with clonazepam. Clinical manifestations, autosomal dominant inheritance and CSF findings suggest a causative role of the SLC2A1 gene, although no splicing defect at the RNA level could be demonstrated for the novel variant. Additional studies such as exome sequencing are indicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.